Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.1 USD | +15.83% | +39.39% | +206.08% |
May. 07 | Canaccord Genuity Adjusts Price Target on Stoke Therapeutics to $20 From $21, Maintains Buy Rating | MT |
May. 06 | Earnings Flash (STOK) STOKE THERAPEUTICS Reports Q1 Revenue $4.2M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+206.08% | 839M | |
+41.79% | 54.04B | |
-0.56% | 41.92B | |
+49.62% | 41.96B | |
-7.20% | 28.35B | |
+12.59% | 26.35B | |
-21.51% | 19B | |
+6.92% | 13B | |
+24.91% | 12.19B | |
+29.60% | 12.28B |
- Stock Market
- Equities
- STOK Stock
- News Stoke Therapeutics, Inc.
- Stoke Therapeutics, Inc. Appoints Jennifer Burstein to Its Board of Directors